Significance of correction of renal anaemia with erythropoietin in haemodialized patients

Acta Medica Croatica

Volumn 59, Issue SUPPL. 1, 2005, Pages 148-154

  Kes, Petar ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTACID AGENT; AZATHIOPRINE; CARNITINE; CISPLATIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ERYTHROPOIETIN ALPHA; ERYTHROPOIETIN BETA; FOLIC ACID; THEOPHYLLINE; UNCLASSIFIED DRUG; UREMIC TOXIN;

ACNE; ANEMIA; BLOOD TRANSFUSION; CHRONIC INFLAMMATION; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONVULSION; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC PROCEDURE; DRUG DOSE TITRATION; DRUG POTENTIATION; ERYTHROPOIESIS; FOLIC ACID DEFICIENCY; HAIR GROWTH; HEMODIALYSIS; HEMOLYSIS; HUMAN; HYPERKALEMIA; HYPERSPLENISM; HYPERTENSION ENCEPHALOPATHY; HYPOPHOSPHATEMIA; IRON DEFICIENCY; LIVER DYSFUNCTION; MICROANGIOPATHY; MUSCLE HYPERTROPHY; PATHOGENESIS; SIDE EFFECT; THROMBOSIS; TREATMENT INDICATION;

EID: 33845675562     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Future challenges in optimizing the use of r-HuEPO in CRF: a satellite symposium at the XIVth international congress of nephrology, Sydney, 1997. NDT 1998; 13 (suppl. 2): S1-S27.
2. Hrvatsko društvo za nefrologiju, dijalizu i transplantaciju. Radna skupina za anemiju u kroničnom zatajenju bubrega. Smjernice za liječenje anemije u kroničnom zatajenju bubrega. Magenta d.o.o., Zagreb 2000; 1-31.
3. Kes P. Temeljna načela liječenja bubrežne anemije pomoću rekombiniranog humanog eritropoetina. Acta clin Croat 1992; 31: 51-68.
4. Kes P, Reiner Ž, Starčevič B, Ratković- Gusić I. Influence of erythropoietin on dialyzer reuse. Blood Purif 1997; 15: 77-83.
5. Kes P. Patogeneza i lijeèenje anemije u bolesnika sa zatajenjem bubrega. Simpozij: eritropoetini su dosegli svoj vrhunac. Zagreb 1999; 3-19.
6. Kes P. Povoljni učinci liječenja bubrežne anemije u ranim stadijima kroničnog zatajenja bubrega. Liječ Vjesn 2002; 124: 108-109.
7. Kes P, Brunetta B. Treba li potpuno ispraviti anemiju u bolesnika s kroničnim zatajenjem bubrega? Liječ Vjesn 2002; 124: 225-227.
8. Mann JFE, Eknoyan G, ur. Benefits of Early Anaemia Treatment in Patients with Renal Insufficiency. Miami, Florida, USA, 4 November 1999. NDT 2000; 15 (Suppl. 3): S1-S44.
9. Mcdougall IC, Ritz E, ur. «nd European Epoetin Symposium Optimizing Anaemia Therapy in CRF, Crete, Greece, 17-19 April 1998. NDT 1999; 14 (Suppl. 2): S1-S92.
10. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. AJKD 1997; 39 (Suppl. 3): S194-S237.
11. NKF-DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. AJKD 2001; 37 (Suppl. 1): S182-S238.
12. Sunder-Plassmann, Horl WH, ur. Erythropoietin and iron. Kidney 1999; 55 (Suppl. 69): S1-S137.
13. Valderrabano F, ur. Past, present and future challenges in renal anaemia. Technical Forum organized by Hoffmann-La Roche Ltd during the 36th ERA/EDTA Congress, Madrid, Spain, septembar 6, 1999. Nephron 2000; 85 (Suppl. 1): S1-S22.
14. Valderrbano F, Horl WH, Jacobs C, Macdougall IC, ur. European Survay on Anaemia Managament (ESAM). NDT 2000; 15 (Suppl. 4): S1-S76.
15. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. European best practice guidelines for the management of anaemia in patients with chronic renal failure. NDT 1999; 14 (suppl. 5): S1-S50.